Différences entre versions de « Péritonite bactérienne spontanée »
De médecine.top
Ligne 21 : | Ligne 21 : | ||
* '''Si critères de PBS présents''' | * '''Si critères de PBS présents''' | ||
** Ceftriaxone 2 g 1x/j (ou lévofloxacine) pdt 5 j '''si ponction d'ascite à 48h stérile et < 250 neutrophiles/μl<ref>Guide d’antibiothérapie empirique chez l’adulte CHUV, édition 2019</ref> | ** Ceftriaxone 2 g 1x/j (ou lévofloxacine) pdt 5 j '''si ponction d'ascite à 48h stérile et < 250 neutrophiles/μl<ref>Guide d’antibiothérapie empirique chez l’adulte CHUV, édition 2019</ref> | ||
− | ** If patients have '''kidney dysfunction''', or '''significant hepatic dysfunction''' as measured by a serum bilirubin level greater than 4 mg/dL (68 µmol/L), adjunctive therapy with albumin (1.5 g/kg body weight on day 1, as well as 1 g/kg on day 3) should be administered; such treatment has a demonstrated survival benefit. | + | ** If patients have '''kidney dysfunction''', or '''significant hepatic dysfunction''' as measured by a serum bilirubin level greater than 4 mg/dL (68 µmol/L), adjunctive therapy with albumin (1.5 g/kg body weight on day 1, as well as 1 g/kg on day 3) should be administered; such treatment has a demonstrated survival benefit = prévention primaire du '''syndrome hépato-rénal'''. |
== Références == | == Références == | ||
[[Category:Gastro-entérologie]] | [[Category:Gastro-entérologie]] |
Version du 20 avril 2020 à 12:51
Diagnostic
- Ponction d'ascite avec numération de leucocytes neutrophiles à ≥250/μl
- Gradient albumine sérum-ascite
Prophylaxie
- Si saignement de varices oesophagiennes
- Ceftriaxone/ciprofloxacine durant 7 jours
- Permet d'éviter les complications d'une translocation bactérienne
- Si patient ascitique à haut risque de PBS
- Criteria for patients at high risk include an ascitic-fluid total protein level less than 1.5 g/dL (15 g/L) in conjunction with any of the following:
- serum sodium level less than or equal to 130 mmol/l,
- serum creatinine level greater than or equal to 106.1 µmol/l,
- blood urea nitrogen level greater than or equal to 8.9 mmol/l,
- serum bilirubin level greater than or equal to 51.3 µmol/l,
- Child-Turcotte-Pugh class B or C cirrhosis.
- Criteria for patients at high risk include an ascitic-fluid total protein level less than 1.5 g/dL (15 g/L) in conjunction with any of the following:
- Si antécédent de PBS
- Patients who have had a bout of SBP should also receive lifelong antibiotic prophylaxis to reduce the risk for recurrence
- Pas de bénéfice démontré de la perfusion d'albumine en prévention primaire
Traitement
- Si critères de PBS présents
- Ceftriaxone 2 g 1x/j (ou lévofloxacine) pdt 5 j si ponction d'ascite à 48h stérile et < 250 neutrophiles/μl[1]
- If patients have kidney dysfunction, or significant hepatic dysfunction as measured by a serum bilirubin level greater than 4 mg/dL (68 µmol/L), adjunctive therapy with albumin (1.5 g/kg body weight on day 1, as well as 1 g/kg on day 3) should be administered; such treatment has a demonstrated survival benefit = prévention primaire du syndrome hépato-rénal.
Références
- ↑ Guide d’antibiothérapie empirique chez l’adulte CHUV, édition 2019